TABLE 1.

Demographic information on the study population

Age groupVaccine typeSampling time (day)nNo. of females/malesAgea (mean yr. ± SD)
Adult (22-49 yr)LAIV0, 10, 282012/829.9 ± 5.7
TIV0, 10, 282412/1233.5 ± 8.7
Child (5-9 yr)LAIV0, 10, 2894/56.0 ± 1.1
0, 10, 4295/47.6 ± 1.3
TIV0, 10, 28214/177.1 ± 1.4
Child (6 mo-4 yr)TIV02412/122.5 ± 1.3
10 after dose 174/33.3 ± 0.8
10 after dose 2105/52.3 ± 1.3
  • a There was no significant difference in age between different vaccine and sampling time groups within each age group.